JBSS 38.71 John B. Sanfilippo & Son $JBSS Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
JBSS 38.71 John B. Sanfilippo & Son $JBSS Hit a 52 week high of 38.71 Closing the day 09:41 at 38.71 +0.41 +1.07% With a day low of 38.30 and a total volume of 2,637.

JBSS Recent Posts: http://investorshangout.com/Sanfilippo-John-B...BSS-54529/

JBSS John B. Sanfilippo & Son Recent Headline News

John B. Sanfilippo & Son, Inc. to Present at the Southwest IDEAS Investor Conference on November 19th & 20th in Dallas
Business Wire - Thu Nov 13, 4:13PM CST
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS), today announced that Mike Valentine, Chief Financial Officer and Frank Pellegrino, Sr. Vice President of Finance will present at the Southwest IDEAS Investor Conference on Thursday, November 20, 2014 at the Marriott - Quorum Hotel in Addison, Texas. John B. Sanfilippo & Son, Inc.'s presentation is scheduled to begin at 1:50 p.m. Central. The presentation will be webcast live and may be accessed at the conference website, www.IDEASConferences.com, or in the investor relations section of the company's website: http://www.jbssinc.com.
JBSS: 39.15 (+0.85)

John B. Sanfilippo & Son declares $1.50 dividend
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:47PM CDT

JBSS: 39.15 (+0.85)

John B. Sanfilippo & Son, Inc. Board Declares Special Cash Dividend of $1.50 per share of Common Stock and $1.50 per share of Class A Common Stock
Business Wire - Tue Oct 28, 4:04PM CDT
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) (the "Company" today announced that its Board of Directors (the "Board" declared a special cash dividend (the "Dividend" of $1.50 per share on all issued and outstanding shares of Common Stock of the Company and $1.50 per share on all issued and outstanding shares of Class A Common Stock of the Company.
JBSS: 39.15 (+0.85)

John B. Sanfilippo & Son Is A Strong Buy For Long Term Investors
Jaxon Research - at Seeking Alpha - Tue Oct 28, 10:24AM CDT

JBSS: 39.15 (+0.85)

Update: John B. Sanfilippo & Son's Weak Fiscal Q1'15
Marshall Hargrave - at Seeking Alpha - Tue Oct 28, 1:55AM CDT

JBSS: 39.15 (+0.85)

John B Sanfilippo & Son's (JBSS) CEO Jeffrey Sanfilippo on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 1:50PM CDT

JBSS: 39.15 (+0.85)

John B. Sanfilippo & Son EPS of $0.53
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 3:27PM CDT

JBSS: 39.15 (+0.85)

John B. Sanfilippo & Son, Inc. Net Sales Increased by 16% on Higher Pricing and Strong Sales Volume
Business Wire - Thu Oct 23, 3:10PM CDT
--Net sales increased by 16.0%
JBSS: 39.15 (+0.85)

Shares of JBSS Up 43.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 20, 9:09AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 6 months, John B. Sanfilippo & Son has returned 43.68% as of today's recent price of $35.03.
JBSS: 39.15 (+0.85)

John B. Sanfilippo & Son, Inc. 1st Quarter Fiscal 2015 Operating Results Conference Call
GlobeNewswire - Fri Oct 17, 4:00PM CDT
John B. Sanfilippo & Son, Inc. (Nasdaq:JBSS), a major processor and distributor of snack and recipe nut products, will hold its quarterly conference call to discuss first quarter fiscal 2015 operating results on Friday, October 24, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). First quarter fiscal 2015 results are expected to be released after the market closes on Thursday, October 23, 2014.
JBSS: 39.15 (+0.85)

Today In SA PRO: Tuesday, October 14
SA PRO Top Ideas - at Seeking Alpha - Wed Oct 15, 4:00AM CDT
Outstanding Performance Award Winner #1: Top Short Idea on MCHX (Marchex, Inc.) by Ariana Research, published July 11, 2014. Return to date: +68% (See author update » ) Outstanding Performance Award Winner #2: PRO Short Idea on ITT...
WATT: 9.22 (+0.19), JBSS: 39.15 (+0.85)

John B. Sanfilippo & Son Has Returned 34.3% Since SmarTrend Recommendation (JBSS)
Comtex SmarTrend(R) - Fri Oct 10, 5:11PM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 5 months, John B. Sanfilippo & Son has returned 34.33% as of today's recent price of $32.75.
JBSS: 39.15 (+0.85)

John B. Sanfilippo & Son Up 32.9% Since SmarTrend Uptrend Call (JBSS)
Comtex SmarTrend(R) - Fri Oct 03, 4:45PM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 5 months, John B. Sanfilippo & Son has returned 32.90% as of today's recent price of $32.40.
JBSS: 39.15 (+0.85)

Fisher Announces Statewide Campaign and $40,000 Donation to Feeding Texas
PR Newswire - Fri Oct 03, 9:00AM CDT
Fisher® Nuts announced a statewide campaign to bring Texas communities together to help feed hungry families this holiday season. In its third year partnering with Feeding Texas (formerly the Texas Food Bank Network) for the Fisher Shares & Cares campaign, Fisher is donating $40,000 that will be used to help feed 400,000 Texans throughout the season.
JBSS: 39.15 (+0.85)

33.6% Return Seen to Date on SmarTrend John B. Sanfilippo & Son Call (JBSS)
Comtex SmarTrend(R) - Fri Sep 26, 10:58AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 5 months, John B. Sanfilippo & Son has returned 33.55% as of today's recent price of $32.56.
JBSS: 39.15 (+0.85)

Shares of JBSS Up 32.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Sep 19, 9:36AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 5 months, John B. Sanfilippo & Son has returned 32.32% as of today's recent price of $32.26.
JBSS: 39.15 (+0.85)

Uptrend Call Working As John B. Sanfilippo & Son Stock Rises 33.0% (JBSS)
Comtex SmarTrend(R) - Fri Sep 12, 9:10AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 4 months, John B. Sanfilippo & Son has returned 32.98% as of today's recent price of $32.42.
JBSS: 39.15 (+0.85)

Fisher Nuts and Chef Alex Guarnaschelli Announce Second Annual "My Fresh Twist" Recipe Contest
PR Newswire - Tue Sep 09, 10:45AM CDT
Fisher® Nuts has announced the second annual "My Fresh Twist" recipe contest today. Beginning now through October 21, 2014 consumers are invited to submit an original recipe using walnuts, almonds or pecans to www.myfreshtwist.com for a chance to win a grand prize that includes a trip for two to New York City to meet Chef Alex Guarnaschelli.
JBSS: 39.15 (+0.85)

John B. Sanfilippo & Son Has Returned 27.8% Since SmarTrend Recommendation (JBSS)
Comtex SmarTrend(R) - Thu Aug 28, 10:58AM CDT
SmarTrend identified an Uptrend for John B. Sanfilippo & Son (NASDAQ:JBSS) on May 1st, 2014 at $24.38. In approximately 4 months, John B. Sanfilippo & Son has returned 27.75% as of today's recent price of $31.15.
JBSS: 39.15 (+0.85)

Sanfilippo (John B.) & Son Inc. (JBSS) Stock Research Links

JBSS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hollywood Vampires' Limited Art Sparks Las Vegas Buzz

Updated Category News Views 10

A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...

Continue Reading
Boardwalk Welcomes New CFO: What This Means for Growth

Updated Category News Views 77

Boardwalk's Leadership Shift: Enter Scott Wexler Nothing spices up a pipeline company's menu like a fresh plate of leadership. Boardwalk Pipelines, out in Houston, just handed the keys to their finance dungeon over to Scott Wexler. He's stepping in as the chief financial officer and senior VP of corporate strategic development, an upgrade that got announced today. Packing...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 164

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
Agrochemicals: Combining Tradition and Innovation

Updated Category News Views 0

The Evolving World of Agrochemicals You know, the agrochemical market isn't just about fertilizers and pesticides anymore. It's evolving into a high-stakes game of innovation, resistance management, and cutting-edge tech. This whole sector's forecast to explode to a whopping US$ 387.7 billion by 2031. That's no small potatoes. Driving Forces: Pests, Drones, and Regulatory...

Continue Reading
Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 44

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
Ozelle's O-Cyte 1: Revolutionizing Hematology with AI

Updated Category News Views 85

O-Cyte 1 Leads the Charge at MEDICA 2026 With all the chatter floating around the latest whiz-bang healthcare technology, it's downright refreshing to stumble upon something as genuinely promising as Ozelle's O-Cyte 1. Slated to be the talk of the town at this year’s MEDICA in DÜSSELDORF, this shiny new automated hematology analyzer promises to marry the best of AI and...

Continue Reading
JumpCloud Tackles Compliance in the AI Era

Updated Category News Views 0

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 7

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Coffee Bean Brews Up Nostalgia with Tiramisu Treats

Updated Category News Views 0

Pouring Old Favorites: The Tiramisu Return When the aromas of coffee and nostalgia waft through the air, it's often a sign that The Coffee Bean & Tea Leaf® is brewing something special. This year, they've decided to double down on the holiday cheer by reintroducing their wildly popular Tiramisu beverage. This ain't just your run-of-the-mill coffee drink—it's a full-on...

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 106

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Market Movements: Insights from Asia and Europe

Updated Category News Views 283

Market Overview: Global Insights The global financial landscape is constantly changing, and recent trends reveal interesting shifts in both Asian and European markets. As we explore these developments, we'll also take a look at how various sectors and commodities are performing, providing a comprehensive overview of current market conditions. U.S. Markets Performance On a...

Continue Reading
XPLR Infrastructure, LP Shareholders: Act Now on Class Action

Updated Category News Views 98

Attention XPLR Infrastructure, LP Investors The Gross Law Firm is reaching out to shareholders of XPLR Infrastructure, LP, formerly known as Nextera Energy Partners, LP (NYSE: XIFR). If you purchased shares during the designated class period, it's crucial to be aware of your rights and potential participation in an upcoming class action lawsuit. Understanding the Class...

Continue Reading
180 Life Sciences Corp. Gears Up for Upcoming Annual Meeting

Updated Category News Views 88

180 Life Sciences Corp. Prepares for Shareholders Meeting 180 Life Sciences Corp. (NASDAQ:ATNF), a pioneering name in the pharmaceutical field, is on track for its upcoming Annual Meeting of Shareholders. This significant event is earmarked for a future date while offering essential insights for those engaged with the company. Important Dates for Shareholders The Board of...

Continue Reading
Investor Alert for iRobot Corporation: Class Action Details Inside

Updated Category News Views 121

Investor Alert for iRobot Corporation Attention all investors: If you’ve faced losses from your investments in iRobot Corporation (NASDAQ: IRBT), it’s crucial to pay attention to recent developments surrounding a significant class action lawsuit. This lawsuit, which involves allegations of securities fraud, may offer a pathway for recovery of your losses. What Is the...

Continue Reading
Exploring the Growth of Dental Bone Graft Substitutes Market

Updated Category News Views 140

Overview of the Dental Bone Graft Substitute Market The dental bone graft substitute market is experiencing impressive growth. This increase is primarily attributed to the rise in dental health issues, the escalation of dental procedures, and the heightened interest in cosmetic dentistry. Recent market predictions suggest this segment could reach USD 1,098.48 million by...

Continue Reading